Ginkgo Bioworks Holdings, Inc. (DNA)
8.31
+0.16
(+1.96%)
USD |
NYSE |
Dec 31, 16:00
8.29
-0.02
(-0.24%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Shareholders Equity (Quarterly): 559.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 503.92M |
| Johnson & Johnson | 79.28B |
| Eli Lilly & Co. | 23.79B |
| Zenas BioPharma, Inc. | 196.43M |
| CEL-SCI Corp. | 15.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.189B |
| Total Liabilities (Quarterly) | 629.38M |
| Debt to Equity Ratio | 0.7554 |
| Current Ratio | 4.39 |
| Net Debt Paydown Yield | 0.71% |